Minor cannabinoids have been gathering interest among growers and extractors over the past year, with research on CBG, CBN, CBC and THC-V showing unique health benefits for consumers. But are consumers even aware of these molecules and is there demand in the marketplace? And are there genetics available that can yield enough of these minor… Continue reading Minor cannabinoids are a ‘new frontier’ in wellness: Q&A with Jonathan Vaught, CEO of Front Range Biosciences